Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus
Madoka Nakajima(Juntendo University), Hiroyuki Arai(Uppsala University), Merja Kokki(Kuopio University Hospital), Ichiro Ogino(Juntendo University), Tuomas Rauramaa(University of Eastern Finland), Ville Leinonen(University of Eastern Finland), Yoshiki Tange(Juntendo University), Kostadin Karagiozov(Juntendo University), Hidenori Sugano(Juntendo University), Akihiro Furuta(Osaka Red Cross Hospital), Nils Danner(University of Eastern Finland), Tadeusz Musialowicz(Kuopio University Hospital), Sanna‐Kaisa Herukka(University of Eastern Finland), Juha E. Jääskeläinen(University of Eastern Finland), Kaito Kawamura(Juntendo University), Antti Junkkari(University of Helsinki), Anne M. Koivisto(University of Helsinki), Mikko Hiltunen(University of Eastern Finland), Petri Mäkinen(University of Eastern Finland), H. K. Jyrkkänen(University of Eastern Finland), Chihiro Kamohara(Juntendo University), M. Miyajima(Juntendo University), Chihiro Akiba(Juntendo University)
Cited by 18
Related Papers
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
|Nature Genetics|2017|1.1k
The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm
|Nature Genetics|2008|727
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
|Alzheimer s & Dementia|2011|412
Family-Based Association between Alzheimer's Disease and Variants in<i>UBQLN1</i>
|New England Journal of Medicine|2005|235